New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis

Abstract Osteoarthritis (OA) is the most common joint disorder and affects approximately half of the aged population. Current treatments for OA are largely palliative until the articular cartilage has been deeply damaged and irreversible morphological changes appear. Thus, effective methods are need...

Full description

Bibliographic Details
Main Authors: Heng Li, Dan Wang, Yongjian Yuan, Jikang Min
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13075-017-1454-2
_version_ 1811333509565906944
author Heng Li
Dan Wang
Yongjian Yuan
Jikang Min
author_facet Heng Li
Dan Wang
Yongjian Yuan
Jikang Min
author_sort Heng Li
collection DOAJ
description Abstract Osteoarthritis (OA) is the most common joint disorder and affects approximately half of the aged population. Current treatments for OA are largely palliative until the articular cartilage has been deeply damaged and irreversible morphological changes appear. Thus, effective methods are needed for diagnosing and monitoring the progression of OA during its early stages when therapeutic drugs or biological agents are most likely to be effective. Various proteinases involved in articular cartilage degeneration in pre-OA conditions, which may represent the earliest reversible measurable changes, are considered diagnostic and therapeutic targets for early OA. Of these proteinases, matrix metalloproteinase 13 (MMP-13) has received the most attention, because it is a central node in the cartilage degradation network. In this review, we highlight the main MMP-13-related changes in OA chondrocytes, including alterations in the activity and expression level of MMP-13 by upstream regulatory factors, DNA methylation, various non-coding RNAs (ncRNAs), and autophagy. Because MMP-13 and its regulatory networks are suitable targets for the development of effective early treatment strategies for OA, we discuss the specific targets of MMP-13, including upstream regulatory proteins, DNA methylation, non-coding RNAs, and autophagy-related proteins of MMP-13, and their therapeutic potential to inhibit the development of OA. Moreover, the various entities mentioned in this review might be useful as early biomarkers and for personalized approaches to disease prevention and treatment by improving the phenotyping of early OA patients.
first_indexed 2024-04-13T16:52:44Z
format Article
id doaj.art-38a69a8ed7e54758bc7f80c62c6b200a
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-04-13T16:52:44Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-38a69a8ed7e54758bc7f80c62c6b200a2022-12-22T02:38:53ZengBMCArthritis Research & Therapy1478-63622017-11-0119111210.1186/s13075-017-1454-2New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritisHeng Li0Dan Wang1Yongjian Yuan2Jikang Min3The First Affiliated Hospital of Huzhou Teachers CollegeThe First Affiliated Hospital of Huzhou Teachers CollegeThe First Affiliated Hospital of Huzhou Teachers CollegeThe First Affiliated Hospital of Huzhou Teachers CollegeAbstract Osteoarthritis (OA) is the most common joint disorder and affects approximately half of the aged population. Current treatments for OA are largely palliative until the articular cartilage has been deeply damaged and irreversible morphological changes appear. Thus, effective methods are needed for diagnosing and monitoring the progression of OA during its early stages when therapeutic drugs or biological agents are most likely to be effective. Various proteinases involved in articular cartilage degeneration in pre-OA conditions, which may represent the earliest reversible measurable changes, are considered diagnostic and therapeutic targets for early OA. Of these proteinases, matrix metalloproteinase 13 (MMP-13) has received the most attention, because it is a central node in the cartilage degradation network. In this review, we highlight the main MMP-13-related changes in OA chondrocytes, including alterations in the activity and expression level of MMP-13 by upstream regulatory factors, DNA methylation, various non-coding RNAs (ncRNAs), and autophagy. Because MMP-13 and its regulatory networks are suitable targets for the development of effective early treatment strategies for OA, we discuss the specific targets of MMP-13, including upstream regulatory proteins, DNA methylation, non-coding RNAs, and autophagy-related proteins of MMP-13, and their therapeutic potential to inhibit the development of OA. Moreover, the various entities mentioned in this review might be useful as early biomarkers and for personalized approaches to disease prevention and treatment by improving the phenotyping of early OA patients.http://link.springer.com/article/10.1186/s13075-017-1454-2Matrix metalloproteinasesMMP-13OsteoarthritisNon-coding RNADNA methylationAutophagy
spellingShingle Heng Li
Dan Wang
Yongjian Yuan
Jikang Min
New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
Arthritis Research & Therapy
Matrix metalloproteinases
MMP-13
Osteoarthritis
Non-coding RNA
DNA methylation
Autophagy
title New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
title_full New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
title_fullStr New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
title_full_unstemmed New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
title_short New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
title_sort new insights on the mmp 13 regulatory network in the pathogenesis of early osteoarthritis
topic Matrix metalloproteinases
MMP-13
Osteoarthritis
Non-coding RNA
DNA methylation
Autophagy
url http://link.springer.com/article/10.1186/s13075-017-1454-2
work_keys_str_mv AT hengli newinsightsonthemmp13regulatorynetworkinthepathogenesisofearlyosteoarthritis
AT danwang newinsightsonthemmp13regulatorynetworkinthepathogenesisofearlyosteoarthritis
AT yongjianyuan newinsightsonthemmp13regulatorynetworkinthepathogenesisofearlyosteoarthritis
AT jikangmin newinsightsonthemmp13regulatorynetworkinthepathogenesisofearlyosteoarthritis